FDA approves Zostavax vaccine to prevent shingles in individuals 50 to 59 years of age

March 25, 2011Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin

The Food and Drug Administration (FDA) today approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. Zostavax is already approved for use in individuals 60 years of age and older.

Food and Drug Recall.org

The Latest Food & Drug Recall and Safety News

FDA approves Zostavax vaccine to prevent shingles in individuals 50 to 59 years of age